​Thank you for your inquiry about CMS347v6 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease. In 2021 the FDA removed pregnancy as a contraindication from prescribing information for the entire class of statins. As such, the Expert Work Group for this measure recommended we remove the denominator exclusion for pregnant women from the measure specifications. Providers can use the denominator exception of Medical Reason for pregnant women who might otherwise qualify for statin therapy. We hope this helps.